FDA approves new treatment for refractory multiple myeloma
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
FDA approves first treatment for neuromyelitis optica spectrum disorder, a rare autoimmune disease of the central nervous system
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
FDA seeks public feedback on new drug approval transparency efforts
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
FDA approves first chemoimmunotherapy regimen for patients with relapsed or refractory diffuse large B-cell lymphoma
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
FDA announces Project Facilitate to assist physicians seeking access to unapproved therapies for patients with cancer
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
FDA approves first anticoagulant (blood thinner) for pediatric patients to treat potentially life-threatening blood clots
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
FDA approves first treatment for children with Lambert-Eaton myasthenic syndrome
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
More Pharma News ...
- FDA approves new treatments for heart disease caused by a serious rare disease, transthyretin mediated amyloidosis
- FDA approves first treatment for pediatric patients with lupus
- FDA permits marketing of first medical device for treatment of ADHD
- FDA approves first generic naloxone nasal spray to treat opioid overdose
- FDA approves first targeted therapy for metastatic bladder cancer
- FDA approves new treatment for osteoporosis in postmenopausal women at high risk of fracture
- FDA expands approved use of metastatic breast cancer treatment to include male patients